Literature DB >> 19003225

Long-term Continuous Production of Monoclonal Antibody by Hybridoma Cells Immobilized in a Fibrous-Bed Bioreactor.

Hui Zhu, Shang-Tian Yang.   

Abstract

The kinetics and long-term stability of continuous production of monoclonal antibody IgG2b by hybridoma HD-24 cells immobilized in a fibrous-bed bioreactor (FBB) were studied for a period of approximately 8 months. The cells were immobilized in the fibrous bed by surface attachment of cells and entrapment of large cell clumps in the void space of the fibrous matrix. A high viable cell density of 1.01 x 10(8)/ml was attained in the bioreactor, which was about 63 times higher than those in conventional T-flask and spinner flask cultures. The continuous FBB produced IgG at a concentration of approximately 0.5 g/l, with reactor productivity of approximately 7 mg/h.l, which was about 23 times higher than those from conventional T-flask and spinner flask cultures. The IgG concentration can be further increased to approximately 0.67 g/l by using higher feed (glucose and glutamine) concentrations and running the reactor at a recycle batch or fed-batch mode. The long-term performance of this bioreactor was also evaluated. For a period of 36 days monitored, the MAb produced in the continuous well-mixed bioreactor at 50 h retention time (0.02/h dilution rate) was maintained at a steady concentration level of approximately 0.3 g/l with less than 8% drift. At the end of the study, it was found that approximately 25% of the cells were strongly attached to the fiber surfaces and the other approximately 75% entrapped or weakly immobilized in the fibrous matrix. The strongly attached cells had a high viability of approximately 90%, compared to approximately 75% for cells weakly immobilized and only approximately 1.4% for freely suspended cells, suggesting that the fibrous matrix preferentially retained and protected the viable (productive) cells. The FBB thus was able to maintain its long-term productivity because nonviable and dead cells were continuously washed off from the fibrous matrix. The high MAb concentration and production rate and excellent stability for continuous long-term production obtained in this study compare favorably to other bioreactor studies reported in the literature. The reactor performance can be further improved by providing better pH and aeration controls at higher feed concentrations. The FBB is easy to operate and scale-up, and thus can be used economically for industrial production of MAb.

Entities:  

Year:  2004        PMID: 19003225      PMCID: PMC3449501          DOI: 10.1023/B:CYTO.0000043395.36188.bc

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  52 in total

1.  A novel perfusion system for animal cell cultures by two step sequential sedimentation.

Authors:  Z Y Wen; X W Teng; F Chen
Journal:  J Biotechnol       Date:  2000-04-14       Impact factor: 3.307

2.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

3.  Antibody production by a hybridoma cell line at high cell density is limited by two independent mechanisms.

Authors:  Michael J Gramer; Tracey L Britton
Journal:  Biotechnol Bioeng       Date:  2002-08-05       Impact factor: 4.530

4.  Modified CelliGen-packed bed bioreactors for hybridoma cell cultures.

Authors:  G Wang; W Zhang; C Jacklin; D Freedman; L Eppstein; A Kadouri
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

5.  Kinetic studies on hybridoma cells immobilized in fixed bed reactors.

Authors:  R Pörtner; S Rössing; M Koop; I Lüdemann
Journal:  Biotechnol Bioeng       Date:  1997-08-05       Impact factor: 4.530

6.  Influence of ammonium on growth, metabolism, and productivity of a continuous suspension Chinese hamster ovary cell culture.

Authors:  H A Hansen; C Emborg
Journal:  Biotechnol Prog       Date:  1994 Jan-Feb

7.  Entrapment of animal cells for production of monoclonal antibodies and other biomolecules.

Authors:  K Nilsson; W Scheirer; O W Merten; L Ostberg; E Liehl; H W Katinger; K Mosbach
Journal:  Nature       Date:  1983-04-14       Impact factor: 49.962

8.  Optimization of monoclonal antibody production: combined effects of potassium acetate and perfusion in a stirred tank bioreactor.

Authors:  W Fong; Y Zhang; P Yung
Journal:  Cytotechnology       Date:  1997-05       Impact factor: 2.058

9.  A fibrous-bed bioreactor for continuous production of developmental endothelial locus-1 by osteosarcoma cells.

Authors:  Chunnuan Chen; Yu Liang Huang; Shang-Tian Yang
Journal:  J Biotechnol       Date:  2002-07-17       Impact factor: 3.307

10.  Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 2. Effects of serum concentration, dissolved oxygen concentration, and medium pH in a batch reactor.

Authors:  S S Ozturk; B O Palsson
Journal:  Biotechnol Prog       Date:  1991 Nov-Dec
View more
  4 in total

1.  Effects of passage number on growth and productivity of hybridoma secreting MRSA anti-PBP2a monoclonal antibodies.

Authors:  Arthur Luiz Corrêa; José Procópio Moreno Senna; Álvaro Paiva Braga de Sousa
Journal:  Cytotechnology       Date:  2015-06-21       Impact factor: 2.058

2.  Repeated-batch production of glucoamylase using recombinant Saccharomyces cerevisiae immobilized in a fibrous bed bioreactor.

Authors:  Peter M Kilonzo; Argyrios Margaritis; Maurice A Bergougnou
Journal:  J Ind Microbiol Biotechnol       Date:  2010-04-21       Impact factor: 3.346

3.  The association between single-nucleotide polymorphisms of ORAI1 gene and breast cancer in a Taiwanese population.

Authors:  Wei-Chiao Chang; Peng Yeong Woon; Yu-Wen Hsu; Shengyu Yang; Yi-Ching Chiu; Ming Feng Hou
Journal:  ScientificWorldJournal       Date:  2012-06-18

4.  Involvement of glycolysis/gluconeogenesis and signaling regulatory pathways in Saccharomyces cerevisiae biofilms during fermentation.

Authors:  Zhenjian Li; Yong Chen; Dong Liu; Nan Zhao; Hao Cheng; Hengfei Ren; Ting Guo; Huanqing Niu; Wei Zhuang; Jinglan Wu; Hanjie Ying
Journal:  Front Microbiol       Date:  2015-02-23       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.